Showing results (191-200 of 257) with videos related to

Sort By:
Pageof 26
Anticancer Research|November 1, 1991
Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic miceL F Massuger, O C Boerman, F H Corstens, et al.
Gynecologic Oncology|March 1, 1993
HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancerP F van Bommel, A J van den Brule, T J Helmerhorst, et al.
Cancer Research|November 15, 1993
Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patientsM R Buist, P Kenemans, W den Hollander, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 3, 1999
Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancerH W Nijman, P Kenemans, R J Poort-Keesom, et al.
European Journal of Clinical Investigation|December 3, 1999
Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion moleculesW M Van Baal, J J Emeis, P Kenemans, et al.
Gynecologic Oncology|January 6, 2000
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutationsR P Zweemer, P J van Diest, R H Verheijen, et al.
Neuroepidemiology|February 15, 2001
Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and designJ D Spence, V J Howard, L E Chambless, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 30, 1998
Menstrual factors in relation to breast cancer riskL Titus-Ernstoff, M P Longnecker, P A Newcomb, et al.
British Journal of Cancer|June 1, 1993
Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesionsF V Cromme, C J Meijer, P J Snijders, et al.
Gynecologic Oncology|February 1, 1994
Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRIM R Buist, R P Golding, C W Burger, et al.
Pageof 26